Evidence on access to medicines for chronic diseases from household surveys in five low- and middle-income countries

Health Policy and Planning

Volumn 30, Issue 8, 2015, Pages 1044-1052

  Vialle Valentin, Catherine E ^a   Serumaga, Brian ^b   Wagner, Anita K ^a   Ross Degnan, Dennis ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JSI RESEARCH AND TRAINING INSTITUTE   (United States)

Author keywords

Access to medicines; household surveys; medicines insurance coverage; non communicable diseases; resource constrained settings

Indexed keywords

ESSENTIAL DRUG;

CHRONIC DISEASE; FAMILY SIZE; GHANA; HEALTH CARE DELIVERY; HUMAN; JORDAN; KENYA; PHILIPPINES; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; UGANDA;

CHRONIC DISEASE; DRUGS, ESSENTIAL; FAMILY CHARACTERISTICS; GHANA; HEALTH SERVICES ACCESSIBILITY; HUMANS; JORDAN; KENYA; PHILIPPINES; UGANDA;

EID: 84943545214     PISSN: 02681080     EISSN: 14602237     Source Type: Journal    
DOI: 10.1093/heapol/czu107     Document Type: Article

References (30)

1. Alleyne G, Binagwaho A, Haines A, et al. (2013). Embedding noncommunicable diseases in the post-2015 development agenda. Lancet 381: 566-74
2. Atun R, Jaffar S, Nishtar S, et al. (2013). Improving responsiveness of health systems to non-communicable diseases. Lancet 381: 690-7
3. Bigdeli M, Jacobs B, Tomson G, et al. (2013). Access to medicines from a health system perspective. Health Policy Plan 28: 692-704
4. Cameron A, Ewen M, Ross-Degnan D, et al. (2009). Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet 373: 240-9
5. Cameron A, Roubos I, Ewen M, et al. (2011). Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries. Bulletin of World Health Organization 89: 412-21
6. Di Cesare M, Khang Y-H, Asaria P, et al. (2013). Inequalities in noncommunicable diseases and effective responses. Lancet 381: 585-97
7. Ensor T, Cooper S. (2004). Overcoming barriers to health service access: influencing the demand side. Health Policy Plan 19: 69-79
8. Embrey M, Hoos D, Quick J. (2009). How AIDS funding strengthens health systems: progress in pharmaceutical management. Journal of Acquired Immune Deficiency Syndrome 52 (Suppl 1): S34-37
9. Evans DB, Hsu J, Boerma T. (2013). Universal health coverage and universal access. Bulletin of the World Health Organization 91: 546-546A
10. Heneghan C, Blacklock C, Perera R, et al. (2013). Evidence for noncommunicable diseases: analysis of Cochrane reviews and randomised trials by World Bank classification. BMJ Open 3: 7 e003298
11. Hogerzeil HV, Liberman J, Wirtz VJ, et al. (2013). Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration. Lancet 381: 680-9
12. James CD, Peabody J, Solon O, et al. (2009). An unhealthy public-private tension: pharmacy ownership, prescribing, and spending in the Philippines. Health Affairs (Millwood) 28: 1022-33
13. Ki-Moon B. Prevention and control of non-communicable diseases-Report of the Secretary-General [Internet]. United Nations. (2011). http://www.un.org/ga/search/view-doc.asp?symbol'A/66/83& Lang'E, accessed 15 January 2014
14. Kotwani A. (2010). Access to essential medicines and standard treatment for chronic diseases. Indian Journal of Pharmacology 42: 127-8
15. Kutzin J. (2013). Health financing for universal coverage and health system performance: concepts and implications for policy. Bulletin of the World Health Organization 91: 602-11
16. Lozano R, Naghavi M, Foreman K, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-128
17. Murray CJL, Vos T, Lozano R, et al. (2012). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-223
18. Mills A, Ataguba JE, Akazili J, et al. (2012). Equity in financing and use of health care in Ghana, South Africa, and Tanzania: implications for paths to universal coverage. Lancet 380: 126-33
19. Patel A, Gauld R, Norris P, et al. (2012). Quality of generic medicines in South Africa: perceptions versus reality-a qualitative study. BMC Health Services Research 12: 297
20. Rilkoff H, Tukahebwa EM, Fleming FM, et al. (2013). Exploring gender dimensions of treatment programmes for neglected tropical diseases in Uganda. PLoS Neglected Tropical Diseases 7: e2312
21. Sachs JD. (2012). Primary health care in low-income countries: building on recent achievements. JAMA 307: 2031-2
22. Thiede M, Akweongo P, McIntyre D. (2007). Exploring the dimensions of access. In: Di McIntyre and Gavin Mooney (eds.) The Economics of Health Equity. pp. 103-123. Cambridge: Cambridge University Press. Available from: Cambridge Books Online. http://dx.doi. org/10.1017/CBO9780511544460.007 [Accessed 08 September 2014]
23. Twagirumukiza M, Cosijns A, Pringels E, et al. (2009). Influence of tropical climate conditions on the quality of antihypertensive drugs from Rwandan pharmacies. American Journal of Tropical Medicine and Hygiene 81: 776-81
24. Van Olmen J, Ku GM, Bermejo R, et al. (2011). The growing caseload of chronic life-long conditions calls for a move towards full self-management in low-income countries. Global Health 7: 38
25. Vialle-Valentin CE, Lecates RF, Zhang F, et al. (2012). Predictors of antibiotic use in African communities: evidence from medicines household surveys in five countries. Tropical Medicine & International Health 17: 211-22
26. Wagner AK, Graves AJ, Reiss SK, et al. (2011). Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey. Health Policy 100: 151-8
27. Wagner AK, Graves AJ, Fan Z, et al. (2013). Need for and access to health care and medicines: are there gender inequities? PLoS ONE 8: e57228
28. World Health Assembly. (2013). Follow-up to the Political Declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. Resolution WHA66.10; 66th World Health Assembly
29. World Health Organization. (2011). Essential Medicines and Health Products (EMP). Pharmaceutical Sector Country Profiles [Internet]. Geneva: World Health Organization. http://www.who.int/medicines/areas/coordination/coordination-assessment/en/index1.html, accessed 15 January 2014
30. World Health Organization. WHO Model List of Essential Medicines, 15th list [Internet]. http://whqlibdoc.who.int/hq/2007/a95075-eng. pdf, accessed 15 January 2014